The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease
Not Applicable
- Conditions
- HCV related chronic liver disease
- Registration Number
- JPRN-UMIN000016750
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Cirrotic patients with BCAA formulation while taking 2) Patients during interferon therapy in chronic hepatitis C, cirrhosis 3) Patients receiving medication for diabetes 4) Patients in the intake of dietary supplements containing the BCAA and zinc 5) Patients for branched-chain amino acids and zinc formulation, with a history of hypersensitivity 6) Pregnant woman and women who may possibly be pregnant, women in nursing
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method